If you invest in the stock market, you must know the Aptus Pharma share price targets for 2026, 2027, 2028, 2029, 2030, 2040, and 2050. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
Table of Contents
About Aptus Pharma Ltd
Aptus Pharma Limited is a fast-growing Indian company that focuses on the marketing and distribution of various pharmaceutical products. They use a special business model where other experts manufacture the medicines while they handle the sales and reach. Their product list includes 194 different items like tablets and liquids that help with stomach issues, allergies, and infections. Investors track the Aptus Pharma share price and market cap because the company is expanding into new areas like life-saving injections. This stock is a popular topic for those looking for small-cap opportunities in the healthcare sector and medical trading industry.
Fundamental Analysis of Aptus Pharma
- Market Cap: ₹295 Cr.
- High / Low: ₹179 / ₹32.3
- Stock P/E: 63.9
- Book Value: ₹13.6
- Dividend Yield: 0.00%
- ROCE: 30.0%
- ROE: 30.5%
- Face Value: ₹10
Aptus Pharma Share Price Target 2026
After analysing past price trends and market performance, it is estimated that the Aptus Pharma stock price could reach a minimum of ₹100 and potentially achieve a maximum target of ₹500 in the year 2026.
Aptus Pharma Share Price Target 2027
After analysing past price trends and market performance, it is estimated that the Aptus Pharma stock price could reach a minimum of ₹300 and potentially achieve a maximum target of ₹800 in the year 2027.
Aptus Pharma Share Price Target 2028
After analysing past price trends and market performance, it is estimated that the Aptus Pharma stock price could reach a minimum of ₹800 and potentially achieve a maximum target of ₹1300 in the year 2028.
Aptus Pharma Share Price Target 2029
After analysing past price trends and market performance, it is estimated that the Aptus Pharma stock price could reach a minimum of ₹1300 and potentially achieve a maximum target of ₹1800 in the year 2029.
Aptus Pharma Share Price Target 2030
After analysing past price trends and market performance, it is estimated that the Aptus Pharma stock price could reach a minimum of ₹1800 and potentially achieve a maximum target of ₹2300 in the year 2030.
Aptus Pharma Share Price Target 2040
After analysing past price trends and market performance, it is estimated that the Aptus Pharma stock price could reach a minimum of ₹5200 and potentially achieve a maximum target of ₹6200 in the year 2040.
Aptus Pharma Share Price Target 2050
After analysing past price trends and market performance, it is estimated that the Aptus Pharma stock price could reach a minimum of ₹10500 and potentially achieve a maximum target of ₹12500 in the year 2050.
Shareholding Pattern of Aptus Pharma
- Promoters: 72.89%
- Retail and Others: 27.11%
Should You Invest in Aptus Pharma Stock?
| Year | Target Price (₹) |
|---|---|
| 2026 | 100–500 |
| 2027 | 300–800 |
| 2028 | 800–1300 |
| 2029 | 1300–1800 |
| 2030 | 1800–2300 |
| 2040 | 5200–6200 |
| 2050 | 10500–12500 |
Whether you should invest or not, it depends on the many factors. Let us know the risk and opportunities to invest in Aptus Pharma stock.
Opportunities
- The company has a very strong track record of high returns on equity for investors.
- Sales and profits have grown quickly which makes the stock attractive for growth buyers.
- They operate with very little debt which keeps the business financially safe and stable.
- A recent bonus issue of shares helps increase the total number of shares available.
- Expansion into ICU care and injectables opens up new ways to make more money.
Risks
- The stock price is trading at a high level compared to its actual book value.
- It takes much longer for the company to collect cash from people who owe money.
- Small-cap stocks like this can have very low trading volume which makes selling difficult.
- The business does not pay out any dividends to shareholders from its yearly profits.
- Operating as a marketing firm means they rely heavily on outside partners for manufacturing.
Key Competitors of Aptus Pharma
Key competitors or peer companies of Aptus Pharma are Zota Health Care, Sunrest Lifescience, Lincoln Pharmaceuticals, Cian Healthcare, Amwill Health Care, Speciality Medicines, AmerisourceBergen, Entero Healthcare, Keimed, and Neelkanth Drugs.
Disclaimer: All the information provided in this article is for educational purposes only. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
